Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.

Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.

Item
http://www.wikidata.org/entity/Q34504963
Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanomaUveal melanoma: From diagnosis to treatment and the science in between.Management of uveal melanoma: a consensus-based provincial clinical practice guidelineBiology of advanced uveal melanoma and next steps for clinical therapeutics.Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastasesResults of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine.Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic ReviewSorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study.Systemic treatment of metastatic uveal melanoma: review of literature and future perspectivesClinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.Update on Metastatic Uveal Melanoma: Progress and Challenges.Emerging growth factor receptor antagonists for the treatment of advanced melanoma.Histologic and immunohistochemical predictors of clinical behavior for feline diffuse iris melanoma.Recent advances in uveal melanoma treatment.Treatment of uveal melanoma: where are we now?
P2860

Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.

Item
http://www.wikidata.org/entity/Q34504963
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Phase II trial of sorafenib in ...... ic uveal melanoma: SWOG S0512.
@ast
Phase II trial of sorafenib in ...... ic uveal melanoma: SWOG S0512.
@en
Phase II trial of sorafenib in ...... ic uveal melanoma: SWOG S0512.
@nl
type
label
Phase II trial of sorafenib in ...... ic uveal melanoma: SWOG S0512.
@ast
Phase II trial of sorafenib in ...... ic uveal melanoma: SWOG S0512.
@en
Phase II trial of sorafenib in ...... ic uveal melanoma: SWOG S0512.
@nl
prefLabel
Phase II trial of sorafenib in ...... ic uveal melanoma: SWOG S0512.
@ast
Phase II trial of sorafenib in ...... ic uveal melanoma: SWOG S0512.
@en
Phase II trial of sorafenib in ...... ic uveal melanoma: SWOG S0512.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Phase II trial of sorafenib in ...... ic uveal melanoma: SWOG S0512.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0048787
P407
P433
P478
P50
P577
P5875
P698
P921
P932